- Home
- SRRK vs NXE Comparison
SRRK vs NXE Comparison
Compare SRRK & NXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SRRK | NXE |
|---|---|---|
| Founded | 2012 | 2011 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6B | 6.2B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | SRRK | NXE |
|---|---|---|
| Price | $42.57 | $10.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $47.88 | N/A |
| AVG Volume (30 Days) | 1.1M | ★ 7.5M |
| Earning Date | 11-14-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $20,271.77 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.71 | $3.91 |
| 52 Week High | $48.28 | $10.37 |
Technical Indicators
Market Signals| Indicator | SRRK | NXE |
|---|---|---|
| Relative Strength Index (RSI) | 50.26 | 66.21 |
| Support Level | $42.61 | $9.05 |
| Resistance Level | $46.14 | $9.66 |
| Average True Range (ATR) | 1.76 | 0.47 |
| MACD | -0.59 | 0.07 |
| Stochastic Oscillator | 18.56 | 94.19 |
Price Performance
Historical ComparisonAbout SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.
About NXE Nexgen Energy Ltd.
NexGen Energy Ltd is an exploration and development entity engaged in acquiring, evaluating, and developing uranium properties in Canada. The company's projects portfolio consists of ROOK I, and the IsoEnergy, at the Athabasca Basin.